Oscar-winning filmmaker Guillermo del Toro was honored with SFFilm's Sloan Science in Cinema Prize for "Frankenstein," an ...

According to a Wall Street Journal report, the company Preventive is working toward genetically engineering its first baby ...

KAIST announced on the 14th of November that it has been selected as a major participating institution in the 'Lunit ...

Most important, of course, is to cut the emissions that are heating the planet. But beyond that, there are ways to help ...

Preliminary geological findings indicate that the regions of Karabakh, Eastern Zangazur, Gazakh-Tovuz, Ganja-Dashkasan, and ...

Detailed price information for Cellectis S.A. ADR (CLLS-Q) from The Globe and Mail including charting and trades.

Ancient dog skulls and DNA reveal a surprising diversity in shape and size over 10,000 years ago, long before modern breeds.

Sam Altman and husband reportedly working to genetically engineer babies from having hereditary disease - Sam Altman and his ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

Animal testing is costly, slow, and poorly predictive. ORIVA offers a human-relevant alternative with the potential to change that.

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...